Loading stock data…
$89.80+0.15 (+0.17%)
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories.
IRADIMED CORPORATION in the Healthcare sector is trading at $89.80 with a market capitalization of $1.1B. Wall Street consensus targets $118.00 (2 analysts), implying a +31.4% move over the next 12 months. The stock is currently 17% below its 52-week high of $107.90, remaining 3.4% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 72 is overbought against a weak tape. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $20.47M↓ | $21.98M↓ | $22.69M↑ | $21.20M↑ | $20.41M |
| Gross Profit | $15.16M↓ | $16.81M↓ | $17.03M↑ | $16.49M↑ | $15.96M |
| Operating Income | $6.39M↓ | $7.24M↑ | $7.09M↑ | $6.83M↑ | $6.79M |
| Net Income | $5.22M↓ | $5.82M↓ | $6.44M↑ | $5.58M↓ | $5.77M |
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers ...